Results for tag: "Rett Syndrome Drug"

Rett Syndrome is a rare neurological disorder that affects the development of the brain in children, primarily girls. It is caused by a mutation in the MECP2 gene. Treatment for Rett Syndrome is largely supportive, but there are a few drugs that have been approved to help manage the symptoms. The Rett Syndrome Drug market is a small but growing segment of the Central Nervous System Drugs market. It is composed of drugs that are used to treat the symptoms of Rett Syndrome, such as seizures, breathing problems, and motor impairments. These drugs are typically prescribed in combination with other therapies, such as physical and occupational therapy. Some of the companies in the Rett Syndrome Drug market include Biogen, Roche, Novartis, and Ovid Therapeutics. These companies are developing drugs that target the underlying cause of Rett Syndrome, as well as drugs that can help manage the symptoms. Show Less Read more